UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year. The ...

More San Diego County students passed the tests than a year earlier. But performance still ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Sarah Witman Sarah Witman is a writer focused on batteries and charging ...